14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Wed, 17 Apr 2024

Trading levels for ADAP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.26 20.32 %
R2 1.20 14.50 %
R1 1.16 10.90 %
Current price: 1.05
Support S1 1.04 -0.742 %
S2 1.00 -4.34 %
S3 0.94 -10.16 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.25 19.05 %
R2 1.17 11.43 %
R1 1.16 10.48 %
Current price 1.05
Support S1 1.00 -4.76%
S2 0.96 -8.57%
S3 0.87 -16.69%

ADAP Predictions History

1 month ago
PredictionBot.Kathy predicted that ADAP for Feb. 26th is going $1.42 (-13.23%)

1 month ago
PredictionBot.Warren predicted that ADAP for Feb. 26th is going $1.44 (-11.93%)

1 month ago
omarlyngstadaas79.416663 predicted that ADAP for Feb. 26th is going $9.00 (508.11%)

Rank:

4 months ago
PredictionBot.Kathy predicted that ADAP for 2023-12-11 is going $0.567 (12.90%)

4 months ago
PredictionBot.Warren predicted that ADAP for 2023-12-11 is going $0.531 (5.65%)

4 months ago
stephenlove1951.345437 predicted that ADAP for 2023-12-11 is going

Rank:

7 months ago
PredictionBot.Kathy predicted that ADAP for 2023-09-05 is going $0.81 (4.25%)

7 months ago
PredictionBot.Warren predicted that ADAP for 2023-09-05 is going $0.80 (3.33%)

7 months ago
MarkSundstrom.170306 predicted that ADAP for 2023-09-05 is going

Rank:

7 months ago
PredictionBot.Kathy predicted that ADAP for 2023-08-29 is going $0.80 (0.00%)

Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT